Dudediligence.

Protagonist Therapeutics, Inc

PTGXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$4.7MSep ’24$170.6MDec ’24$28.3MMar ’25$5.5MJun ’25$4.7MSep ’25$7.4MDec ’25$56.4MMar ’26$213.5MJun ’26
Net income, by quarter
−$33.2MSep ’24$131.7MDec ’24−$11.7MMar ’25−$34.8MJun ’25−$39.3MSep ’25−$44.4MDec ’25$3.8MMar ’26$162.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$27.4M$26.6M$60.0M$434.4M$46.0M
Operating income−$125.8M−$131.4M−$93.7M$252.8M−$158.1M
Net income−$125.6M−$127.4M−$79.0M$275.2M−$130.1M
Operating cash flow−$107.9M−$108.1M−$70.2M$184.2M$57.7M
Free cash flow−$109.0M−$108.9M−$70.8M$182.8M$56.1M
Cash$123.7M$125.7M$186.7M$97.2M$128.4M
Shares outstanding47.8M49.3M57.7M61.0M62.6M